BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang CC, Chang CW, Nguyen PA, Chang TH, Shih YL, Chang WY, Horng JT, Lee OK, Ho JH. Ankylosing spondylitis and the risk of cancer. Oncol Lett 2017;14:1315-22. [PMID: 28789346 DOI: 10.3892/ol.2017.6368] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Alehashemi S, Ward MM. Risk of Hematologic Malignancies in Elderly Patients With Ankylosing Spondylitis: A Cohort Study and Systematic Review. Mayo Clin Proc 2023;98:100-10. [PMID: 36470752 DOI: 10.1016/j.mayocp.2022.06.030] [Reference Citation Analysis]
2 Kiranatlioglu-firat F, Demir H, Cuce I, Altın-celik P, Eciroglu H, Bayram F, Donmez-altuntas H. Increased oxidative and chromosomal DNA damage in patients with ankylosing spondylitis: its role in pathogenesis. Clin Exp Med 2022. [DOI: 10.1007/s10238-022-00957-3] [Reference Citation Analysis]
3 Eshwar V, Kamath A, Shastry R, Shenoy AK, Kamath P. A Review of the Safety of Interleukin-17A Inhibitor Secukinumab. Pharmaceuticals 2022;15:1365. [DOI: 10.3390/ph15111365] [Reference Citation Analysis]
4 Ao Y, Wen Y, Li Y, Peng H, Wu X, Wang Z, Jiang Y, Lin Y, Li S. Ankylosing Spondylitis and the Risk of Lung Cancer: A Meta-Analysis and Mendelian Randomization. Front Genet 2022;13:861984. [DOI: 10.3389/fgene.2022.861984] [Reference Citation Analysis]
5 Chung HY, Chan SCW, Sun FSK. Risk of nonpulmonary infections requiring hospitalization in spondyloarthritis. Immunity Inflam & Disease 2022;10. [DOI: 10.1002/iid3.615] [Reference Citation Analysis]
6 Losada-garcía A, Cortés-ramírez S, Cruz-burgos M, Morales-pacheco M, Cruz-hernández CD, Gonzalez-covarrubias V, Perez-plascencia C, Cerbón M, Rodríguez-dorantes M. Hormone-Related Cancer and Autoimmune Diseases: A Complex Interplay to be Discovered. Front Genet 2022;12:673180. [DOI: 10.3389/fgene.2021.673180] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 de Jesus Guimarães C, da Silva Costa PM, de Brito Vieira Neto J, Guimarães AC. Chemotherapy for Rheumatology. The Golden Guide to Oncologic Pharmacy 2022. [DOI: 10.1007/978-3-030-98596-7_16] [Reference Citation Analysis]
8 Lari A, Pourbadie HG, Sharifi-Zarchi A, Akhtari M, Samimi LN, Jamshidi A, Mahmoudi M. Dysregulation of ribosome-related genes in ankylosing spondylitis: a systems biology approach and experimental method. BMC Musculoskelet Disord 2021;22:789. [PMID: 34521416 DOI: 10.1186/s12891-021-04662-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Batra V, Batta NS, Gupta A. Toxic flare phenomenon in osteoblastoma: A case report with literature review. IJMSR 2021;3:106-110. [DOI: 10.25259/ijmsr_59_2020] [Reference Citation Analysis]
10 Tournadre A, Sellam J, Morel J, Jullien D, Bouhnik Y, Cornec D, Devauchelle-Pensec V, Goupille P, Kluger N, Lazaro E, Goff BL, Lédinghen V, Lequerré T, Nocturne G, Seror R, Truchetet ME, Verhoeven F, Richez C, Pham T. Practical management of patients on anti-IL17 therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine 2021;88:105210. [PMID: 34074455 DOI: 10.1016/j.jbspin.2021.105210] [Reference Citation Analysis]
11 Chung MK, Lee CH, Park JS, Lim H, Lee J. Burden of comorbidities and medication use in childbearing women with rheumatic diseases: a nationwide population-based study. Korean J Intern Med 2021. [PMID: 34233434 DOI: 10.3904/kjim.2021.089] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Ward MM, Alehashemi S. Risks of solid cancers in elderly persons with osteoarthritis or ankylosing spondylitis. Rheumatology (Oxford) 2020;59:3817-25. [PMID: 32442295 DOI: 10.1093/rheumatology/keaa166] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
13 Kelty E, Raymond W, Inderjeeth C, Keen H, Nossent J, Preen DB. Cancer diagnosis and mortality in patients with ankylosing spondylitis: A Western Australian retrospective cohort study. Int J Rheum Dis 2021;24:216-22. [PMID: 33252845 DOI: 10.1111/1756-185X.14036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chang H, Shin YW, Keam B, Kim M, Im SA, Lee ST. HLA-B27 association of autoimmune encephalitis induced by PD-L1 inhibitor. Ann Clin Transl Neurol 2020;7:2243-50. [PMID: 33031633 DOI: 10.1002/acn3.51213] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
15 Karmacharya P, Shahukhal R, Ogdie A. Risk of Malignancy in Spondyloarthritis: A Systematic Review. Rheum Dis Clin North Am 2020;46:463-511. [PMID: 32631600 DOI: 10.1016/j.rdc.2020.04.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
16 Lin L, Zhao L, Huo B, Zheng L, Yu R, Li W, Yang J. Membranous nephropathy and thymoma in a patient with ankylosing spondylitis: A case report. Medicine (Baltimore) 2020;99:e20111. [PMID: 32358402 DOI: 10.1097/MD.0000000000020111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Lérias JR, Paraschoudi G, de Sousa E, Martins J, Condeço C, Figueiredo N, Carvalho C, Dodoo E, Castillo-Martin M, Beltrán A, Ligeiro D, Rao M, Zumla A, Maeurer M. Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized Immunotherapies. Front Cell Dev Biol 2019;7:362. [PMID: 32039196 DOI: 10.3389/fcell.2019.00362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
18 Nam B, Kim H, Jang EJ, Cho S, Sung Y, Kim T. Malignancy risk in Korean male patients with ankylosing spondylitis. Rheumatol Int 2019;39:1741-8. [DOI: 10.1007/s00296-019-04408-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
19 Scriffignano S, Perrotta FM, De Socio A, Lubrano E. Role of comorbidities in spondyloarthritis including psoriatic arthritis. Clin Rheumatol 2019;38:3-10. [DOI: 10.1007/s10067-018-4332-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]